Regenicin Stock Price on December 10, 2024
| RGIN Stock | USD 0.0001 0.00 0.00% |
If you're considering investing in Regenicin Pink Sheet, it is important to understand the factors that can impact its price. As of today, the current price of Regenicin stands at 0.0001, as last reported on the 13th of December 2024, with the highest price reaching 0.0001 and the lowest price hitting 0.0001 during the day. We have found three technical indicators for Regenicin, which you can use to evaluate the volatility of the company.
Regenicin Pink Sheet price history is provided at the adjusted basis, taking into account all of the recent filings.
Regenicin |
Sharpe Ratio = 0.0
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| RGIN |
Based on monthly moving average Regenicin is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Regenicin by adding Regenicin to a well-diversified portfolio.
Related Headline
Cardiff Oncology Headline on 10th of December 2024
Cardiff stock soars on onvansertib data, 40M direct offering by seekingalpha.com
Cardiff Oncology stock rallied 46 percent Tuesday after it reported positive data for its oncology drug onvansertib and priced a 40M registered direct offering. Read more here.
Regenicin Valuation on December 10, 2024
It is possible to determine the worth of Regenicin on a given historical date. On December 10, 2024 Regenicin was worth 1.0E-4 at the beginning of the trading date compared to the closed value of 1.0E-4. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Regenicin pink sheet. Still, in general, we apply an absolute valuation method to find Regenicin's value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Regenicin where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Regenicin's related companies.
| Open | High | Low | Close | Volume | |
| 0.0001 | 0.0001 | 0.0001 | 0.0001 | 1.00 | |
12/10/2024 | 0.0001 | 0.0001 | 0.0001 | 0.0001 | 1.00 |
| 0.0001 | 0.0001 | 0.0001 | 0.0001 | 1.00 |
| Backtest Regenicin | | | Regenicin History | | | Regenicin Valuation | Previous | Next |
Regenicin Trading Date Momentum on December 10, 2024
| On December 11 2024 Regenicin was traded for 0.0001 at the closing time. The top price for the day was 0.0001 and the lowest listed price was 0.0001 . There was no trading activity during the period 1.0. Lack of trading volume on December 11, 2024 did not cause price change. The trading delta at closing time against the current closing price is 0.00% . |
Regenicin Fundamentals Correlations and Trends
By evaluating Regenicin's financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Regenicin's main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Regenicin financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Regenicin Pink Sheet history
Regenicin investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Regenicin is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Regenicin will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Regenicin stock prices may prove useful in developing a viable investing in Regenicin
Regenicin, Inc. focuses on developing and commercializing a technology of tissue-engineered skin substitutes. Regenicin, Inc. was incorporated in 2007 and is headquartered in Little Falls, New Jersey. Regenicin operates under Biotechnology classification in the United States and is traded on OTC Exchange. It employs 3 people.
Regenicin Pink Sheet Technical Analysis
Regenicin technical pink sheet analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, pink sheet market cycles, or different charting patterns.
Price Boundaries
Regenicin Period Price Range
Low | December 13, 2024
| High |
0.00 | 0.00 |
Regenicin cannot be verified against its exchange. Please verify the symbol is currently traded on PINK Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Regenicin December 13, 2024 Market Strength
Market strength indicators help investors to evaluate how Regenicin pink sheet reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Regenicin shares will generate the highest return on investment. By undertsting and applying Regenicin pink sheet market strength indicators, traders can identify Regenicin entry and exit signals to maximize returns
Other Information on Investing in Regenicin Pink Sheet
Regenicin financial ratios help investors to determine whether Regenicin Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Regenicin with respect to the benefits of owning Regenicin security.